Single-Cell Multi-Omics Market By Type (Single Cell Genomics, Single Cell Transcriptomics and Proteomics, and Single Cell Metabolomics), By Product (Instruments and Consumables), By Workflow (Single Cell Isolation, Single Cell Preparation, and Single Cell Analysis), By Application (Oncology, Immunology, Neurology, Microbiology, Stem Cell, Cell Biology, and Others), By End-User (Research and Academic Laboratories, Biopharmaceutical and Biotech Companies, and Others),By Region - Trends, Analysis and Forecast till 2034

Single-Cell Multi-Omics Market was valued at USD 2.9 Billion in 2024 and is projected to grow at a CAGR of 14.8% to reach USD 11.5 Billion by 2034.

The single-cell multi-omics measures the multiple types of the molecule from the single cell of the same individual. The multi-omics enables the data from the various omics platforms. The multi-omics insight into inter-relation of the omics layers on the process of the diseases. The single-cell sequencing technology divided into genotypic and phenotypic which helps to determine the mechanisms to govern the diseases and health.

The advancement and development in the next-generation sequencing technique for the diagnosis of oncology, immunology, and other is the major propelling factor for the growth of the single-cell multi-omics market. According to the World Health Organization (WHO), effective and timely treatment of ID can both raise national productivity levels by as much as 20% and also rise in restore personal health. Moreover, non-invasive diagnosis is advance technology, it overcomes the challenge of heterogeneity associated with bulk cell populations that increases the need for non- invasive diagnosis is the propelling factor for the growth of the target market. Additionally, the adoption of the personalized medicine which is another boosting factor for the growth of the market. However, lack in tools for the computational analysis and the requirement of high capitals is the major restraining factor for the growth of the market. Nevertheless, increasing funding in the research of single-cell multi-omics can create an opportunity for the growth of the target market.

The single-cell multi-omics market is segmented based on type, product, workflow, end-user, and region.

Based on type, the single-cell multi-omics market is segmented into single-cell genomics, single-cell transcriptomics and proteomics, and single-cell metabolomics. Based on the product, the target market is segmented into instruments and consumables. Based on workflow, the global market is classified into single-cell isolation, single-cell preparation, and single-cell analysis. Based on the application, the target market is divided into oncology, immunology, neurology, microbiology, stem cell, cell biology, and others. Oncology is the major dominating segment for the global market due to the increasing advancement of single-cell technology to treat cancer. Based on end-user, the target market is bifurcated into research and academic laboratories, biopharmaceutical and biotech companies, and others.

Regional Insights:

Based on the region the single-cell multi-omics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the single-cell multi-omics market due to the increase in adoption of the single-cell technology which is driven by various government initiatives. In the European region single-cell, the multi-omics market is projected to register a high CAGR over the forecast period due to increasing healthcare system and its infrastructure.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Single-Cell Multi-Omics Market report based on type, product, workflow, end-user, and region:

Single-Cell Multi-Omics Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the single-cell multi-omics market involves 1CellBio, 10X Genomics Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., Spatial Transcriptomics, Fluidigm Corporation, Fluxion Biosciences, NanoString Technologies, Inc., and Illumina, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the product to gain a competitive edge in the target market. For instance, 10X Genomics Inc. acquired the Spatial Transcriptomics to increase the product portfolio in the sector of transcriptomics analysis, in 2018.

• 1CellBio
• 10x Genomics Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BGI Genomics Co. Ltd.
• Spatial Transcriptomics
• Fluidigm Corporation
• Fluxion Biosciences
• NanoString Technologies, Inc.
• Illumina, Inc.